$BSTCE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOSPECIFICS TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOSPECIFICS TECHNOLOGIES CORP. Get notifications about new insider transactions in BIOSPECIFICS TECHNOLOGIES CORP for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | HUTCHISON PATRICK | Chief Financial Off ... | Option Exercise | D | 56.21 | 10,000 | 562,100 | 0 | |
| Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Option Exercise | D | 55.63 | 6,000 | 333,780 | 0 | |
| Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | HUTCHISON PATRICK | Chief Financial Off ... | Option Exercise | D | 56.21 | 10,000 | 562,100 | 0 | |
| Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Sell | D | 0.00 | 2,018 | 0 | 0 | 2 K to 0 (-100.00 %) |
| Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Option Exercise | D | 55.63 | 6,000 | 333,780 | 0 | |
| Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Sell | D | 0.00 | 2,018 | 0 | 0 | 2 K to 0 (-100.00 %) |
| Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Grant | A | 0.00 | 1,726 | 0 | 18,616 | 16.9 K to 18.6 K (+10.22 %) |
| Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Grant | A | 0.00 | 1,726 | 0 | 3,616 | 1.9 K to 3.6 K (+91.32 %) |
| Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Grant | A | 0.00 | 1,726 | 0 | 3,646 | 1.9 K to 3.6 K (+89.90 %) |
| Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Grant | A | 0.00 | 1,726 | 0 | 68,888 | 67.2 K to 68.9 K (+2.57 %) |
| Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Grant | A | 0.00 | 1,726 | 0 | 117,616 | 115.9 K to 117.6 K (+1.49 %) |
| May 29 2020 | BSTCE | BIOSPECIFICS TECHN ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 63.72 | 130,000 | 8,283,600 | 130,000 | |
| May 04 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Option Exercise | A | 55.63 | 6,000 | 333,780 | 6,000 | |
| May 04 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Option Exercise | A | 55.63 | 6,000 | 333,780 | 6,000 | |
| Apr 15 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Grant | A | 0.00 | 2,018 | 0 | 2,018 | 0 to 2 K |
| Apr 15 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Grant | A | 0.00 | 2,018 | 0 | 2,018 | 0 to 2 K |
| Mar 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Option Exercise | A | 55.62 | 5,000 | 278,100 | 5,000 | |
| Jan 10 2020 | BSTCE | BIOSPECIFICS TECHN ... | HUTCHISON PATRICK | Chief Financial Off ... | Option Exercise | A | 56.21 | 10,000 | 562,100 | 10,000 | |
| Jan 10 2020 | BSTCE | BIOSPECIFICS TECHN ... | HUTCHISON PATRICK | Chief Financial Off ... | Option Exercise | A | 56.21 | 10,000 | 562,100 | 10,000 | |
| Nov 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | CALDWELL PATRICK M | Principal Financial ... | Grant | A | 0.00 | 500 | 0 | 1,000 | 500 to 1,000 (+100.00 %) |
| Oct 25 2019 | BSTCE | BIOSPECIFICS TECHN ... | BUCHI J KEVIN | Chief Executive Off ... | Option Exercise | A | 46.52 | 85,000 | 3,954,200 | 85,000 | |
| Oct 25 2019 | BSTCE | BIOSPECIFICS TECHN ... | BUCHI J KEVIN | Chief Executive Off ... | Option Exercise | A | 46.52 | 85,000 | 3,954,200 | 85,000 | |
| Oct 25 2019 | BSTCE | BIOSPECIFICS TECHN ... | BUCHI J KEVIN | Chief Executive Off ... | Option Exercise | A | 46.52 | 85,000 | 3,954,200 | 85,000 | |
| Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.16 | 8,900 | 490,924 | 935,073 | 944 K to 935.1 K (-0.94 %) |
| Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.16 | 8,900 | 490,924 | 935,073 | 944 K to 935.1 K (-0.94 %) |
| Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.23 | 1,100 | 60,753 | 943,973 | 945.1 K to 944 K (-0.12 %) |
| Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.23 | 1,100 | 60,753 | 943,973 | 945.1 K to 944 K (-0.12 %) |
| Sep 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | M | 26.43 | 15,000 | 396,450 | 0 | |
| Sep 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Buy | M | 26.43 | 15,000 | 396,450 | 115,890 | 100.9 K to 115.9 K (+14.87 %) |
| Sep 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | M | 26.43 | 15,000 | 396,450 | 0 | |
| Sep 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Buy | M | 26.43 | 15,000 | 396,450 | 115,890 | 100.9 K to 115.9 K (+14.87 %) |
| Jul 03 2019 | BSTCE | BIOSPECIFICS TECHN ... | CALDWELL PATRICK M | Principal Financial ... | Grant | A | 0.00 | 500 | 0 | 500 | 0 to 500 |
| Jul 03 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Grant | A | 0.00 | 1,890 | 0 | 1,920 | 30 to 1.9 K (+6,300.00 %) |
| Jul 02 2019 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Grant | A | 0.00 | 1,890 | 0 | 100,890 | 99 K to 100.9 K (+1.91 %) |
| Jul 02 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Grant | A | 0.00 | 1,890 | 0 | 1,890 | 0 to 1.9 K |
| Jul 02 2019 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Grant | A | 0.00 | 1,890 | 0 | 16,890 | 15 K to 16.9 K (+12.60 %) |
| Jul 02 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Grant | A | 0.00 | 1,890 | 0 | 667,162 | 665.3 K to 667.2 K (+0.28 %) |
| Jun 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 58.55 | 459 | 26,874 | 30 | 489 to 30 (-93.87 %) |
| Jun 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 57.25 | 500 | 28,625 | 489 | 989 to 489 (-50.56 %) |
| Jun 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 58.01 | 2,411 | 139,862 | 989 | 3.4 K to 989 (-70.91 %) |
| Jun 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 56.56 | 2,600 | 147,056 | 3,400 | 6 K to 3.4 K (-43.33 %) |
| Jun 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 57.25 | 500 | 28,625 | 489 | 989 to 489 (-50.56 %) |
| Jun 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 58.01 | 2,411 | 139,862 | 989 | 3.4 K to 989 (-70.91 %) |
| Jun 06 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 56.56 | 2,600 | 147,056 | 3,400 | 6 K to 3.4 K (-43.33 %) |
| Jun 05 2019 | BSTCE | BIOSPECIFICS TECHN ... | CALDWELL PATRICK M | Principal Financial ... | Sell | S | 58.80 | 6,000 | 352,800 | 0 | 6 K to 0 (-100.00 %) |
| Jun 05 2019 | BSTCE | BIOSPECIFICS TECHN ... | CALDWELL PATRICK M | Principal Financial ... | Sell | S | 58.80 | 6,000 | 352,800 | 0 | 6 K to 0 (-100.00 %) |
| Jun 03 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 60.74 | 3,313 | 201,232 | 6,000 | 9.3 K to 6 K (-35.57 %) |
| May 28 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 61.09 | 7,800 | 476,502 | 65,272 | 73.1 K to 65.3 K (-10.67 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | M | 41.82 | 3,750 | 156,825 | 11,250 | |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | M | 37.64 | 15,000 | 564,600 | 0 | |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Sell | S | 62.06 | 18,750 | 1,163,625 | 376 | 19.1 K to 376 (-98.03 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Buy | M | 41.82 | 3,750 | 156,825 | 19,126 | 15.4 K to 19.1 K (+24.39 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Buy | M | 37.64 | 15,000 | 564,600 | 15,376 | 376 to 15.4 K (+3,989.36 %) |
| May 23 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Option Exercise | M | 37.64 | 8,000 | 301,120 | 1,687 | |
| May 23 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Buy | M | 37.64 | 8,000 | 301,120 | 9,313 | 1.3 K to 9.3 K (+609.29 %) |
| May 23 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 63.70 | 1,200 | 76,440 | 73,072 | 74.3 K to 73.1 K (-1.62 %) |
| May 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 64.67 | 100 | 6,467 | 945,073 | 945.2 K to 945.1 K (-0.01 %) |
| May 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 64.05 | 5,400 | 345,887 | 945,173 | 950.6 K to 945.2 K (-0.57 %) |
| May 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 64.04 | 6,000 | 384,236 | 74,272 | 80.3 K to 74.3 K (-7.47 %) |
| May 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 64.04 | 6,000 | 384,236 | 74,272 | 80.3 K to 74.3 K (-7.47 %) |
| May 21 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 64.00 | 2,000 | 128,000 | 1,313 | 3.3 K to 1.3 K (-60.37 %) |
| May 21 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Sell | S | 63.43 | 2,000 | 126,860 | 3,313 | 5.3 K to 3.3 K (-37.64 %) |
| May 21 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Option Exercise | M | 37.64 | 5,313 | 199,981 | 0 | |
| May 21 2019 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Buy | M | 37.64 | 5,313 | 199,981 | 5,313 | 0 to 5.3 K |
| May 17 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Option Exercise | M | 20.95 | 15,000 | 314,250 | 0 | |
| May 17 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Buy | M | 20.95 | 15,000 | 314,250 | 80,272 | 65.3 K to 80.3 K (+22.98 %) |
| May 17 2019 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 65.83 | 5,000 | 329,150 | 15,000 | 20 K to 15 K (-25.00 %) |
| Sep 11 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 58.66 | 1,000 | 58,655 | 65,272 | 66.3 K to 65.3 K (-1.51 %) |
| Sep 11 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 57.31 | 5,500 | 315,206 | 66,272 | 71.8 K to 66.3 K (-7.66 %) |
| Sep 07 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 57.64 | 1,000 | 57,637 | 20,000 | 21 K to 20 K (-4.76 %) |
| Aug 30 2018 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | M | 20.00 | 15,000 | 300,000 | 0 | |
| Aug 30 2018 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Buy | M | 20.00 | 15,000 | 300,000 | 99,000 | 84 K to 99 K (+17.86 %) |
| Aug 29 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 49.79 | 5,000 | 248,973 | 20,000 | 25 K to 20 K (-20.00 %) |
| Aug 29 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 48.88 | 5,000 | 244,416 | 25,000 | 30 K to 25 K (-16.67 %) |
| Aug 29 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 50.11 | 10,000 | 501,144 | 30,000 | 40 K to 30 K (-25.00 %) |
| Aug 27 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 51.09 | 6,400 | 326,962 | 40,000 | 46.4 K to 40 K (-13.79 %) |
| Aug 27 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 51.27 | 5,425 | 278,166 | 46,400 | 51.8 K to 46.4 K (-10.47 %) |
| Aug 27 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 51.09 | 6,400 | 326,962 | 40,000 | 46.4 K to 40 K (-13.79 %) |
| Aug 27 2018 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Sell | S | 51.27 | 5,425 | 278,166 | 46,400 | 51.8 K to 46.4 K (-10.47 %) |
| Aug 23 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 52.56 | 4,698 | 246,929 | 71,772 | 76.5 K to 71.8 K (-6.14 %) |
| Aug 23 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 52.71 | 3,802 | 200,393 | 76,470 | 80.3 K to 76.5 K (-4.74 %) |
| Aug 23 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 52.56 | 4,698 | 246,929 | 71,772 | 76.5 K to 71.8 K (-6.14 %) |
| Aug 23 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Sell | S | 52.71 | 3,802 | 200,393 | 76,470 | 80.3 K to 76.5 K (-4.74 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 51.89 | 2,500 | 129,728 | 947,473 | 950 K to 947.5 K (-0.26 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 48.08 | 10,000 | 480,832 | 949,973 | 960 K to 950 K (-1.04 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 41.21 | 3,100 | 127,751 | 959,973 | 963.1 K to 960 K (-0.32 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 37.55 | 3,605 | 135,350 | 963,073 | 966.7 K to 963.1 K (-0.37 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 37.50 | 1,266 | 47,475 | 966,678 | 967.9 K to 966.7 K (-0.13 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 37.53 | 7,935 | 297,824 | 967,944 | 975.9 K to 967.9 K (-0.81 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 37.50 | 2,692 | 100,957 | 975,879 | 978.6 K to 975.9 K (-0.28 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 37.61 | 1,607 | 60,440 | 978,571 | 980.2 K to 978.6 K (-0.16 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 33.00 | 24,750 | 816,750 | 980,178 | 1 M to 980.2 K (-2.46 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 34.11 | 50 | 1,706 | 1,004,928 | 1 M to 1 M (0.00 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 33.14 | 150 | 4,971 | 1,004,978 | 1 M to 1 M (-0.01 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Estate of Edwin H. Wegman | 10% Owner | Sell | S | 33.80 | 50 | 1,690 | 1,005,128 | 1 M to 1 M (0.00 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 51.89 | 2,500 | 129,728 | 947,473 | 950 K to 947.5 K (-0.26 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 51.89 | 2,500 | 129,728 | 947,473 | 950 K to 947.5 K (-0.26 %) |
| Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 51.23 | 21,092 | 1,080,566 | 291,327 | 312.4 K to 291.3 K (-6.75 %) |
| Aug 15 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 50.00 | 7,921 | 396,056 | 312,419 | 320.3 K to 312.4 K (-2.47 %) |
| Aug 15 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 51.21 | 15,987 | 818,646 | 320,340 | 336.3 K to 320.3 K (-4.75 %) |
| Aug 15 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 50.00 | 7,921 | 396,056 | 312,419 | 320.3 K to 312.4 K (-2.47 %) |
| Aug 15 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 51.21 | 15,987 | 818,646 | 320,340 | 336.3 K to 320.3 K (-4.75 %) |
| Aug 02 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | C | 21.00 | 50,000 | 1,050,000 | 0 | |
| Aug 02 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | C | 21.00 | 50,000 | 1,050,000 | 0 | |
| Aug 02 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | C | 21.00 | 50,000 | 1,050,000 | 336,327 | 286.3 K to 336.3 K (+17.46 %) |
| Aug 02 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | C | 21.00 | 50,000 | 1,050,000 | 336,327 | 286.3 K to 336.3 K (+17.46 %) |
| Jun 20 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Option Exercise | C | 17.00 | 15,000 | 255,000 | 0 | |
| Jun 20 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Buy | C | 17.00 | 15,000 | 255,000 | 80,272 | 65.3 K to 80.3 K (+22.98 %) |
| Jun 04 2018 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | C | 13.60 | 15,000 | 204,000 | 0 | |
| Jun 04 2018 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Buy | C | 13.60 | 15,000 | 204,000 | 84,000 | 69 K to 84 K (+21.74 %) |
| Jun 04 2018 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | C | 13.60 | 15,000 | 204,000 | 0 | |
| Jun 04 2018 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Buy | C | 13.60 | 15,000 | 204,000 | 84,000 | 69 K to 84 K (+21.74 %) |
| Mar 19 2018 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Option Exercise | A | 41.82 | 15,000 | 627,300 | 15,000 | |
| Mar 19 2018 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | A | 41.82 | 15,000 | 627,300 | 15,000 | |
| Dec 13 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 49.54 | 15,000 | 743,112 | 930,879 | 945.9 K to 930.9 K (-1.59 %) |
| Nov 29 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 48.08 | 10,000 | 480,832 | 949,973 | 960 K to 950 K (-1.04 %) |
| Nov 29 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 48.08 | 10,000 | 480,832 | 949,973 | 960 K to 950 K (-1.04 %) |
| Nov 29 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 48.32 | 8,945 | 432,188 | 955,879 | 964.8 K to 955.9 K (-0.93 %) |
| Nov 29 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 48.04 | 11,055 | 531,048 | 964,824 | 975.9 K to 964.8 K (-1.13 %) |
| Sep 16 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 41.21 | 3,100 | 127,751 | 959,973 | 963.1 K to 960 K (-0.32 %) |
| Sep 16 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 41.21 | 3,100 | 127,751 | 959,973 | 963.1 K to 960 K (-0.32 %) |
| Sep 13 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 37.55 | 3,605 | 135,350 | 963,073 | 966.7 K to 963.1 K (-0.37 %) |
| Sep 13 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 37.55 | 3,605 | 135,350 | 963,073 | 966.7 K to 963.1 K (-0.37 %) |
| Sep 02 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.50 | 1,266 | 47,475 | 966,678 | 967.9 K to 966.7 K (-0.13 %) |
| Sep 02 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.53 | 7,935 | 297,824 | 967,944 | 975.9 K to 967.9 K (-0.81 %) |
| Sep 02 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 37.50 | 1,266 | 47,475 | 966,678 | 967.9 K to 966.7 K (-0.13 %) |
| Sep 02 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 37.53 | 7,935 | 297,824 | 967,944 | 975.9 K to 967.9 K (-0.81 %) |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.50 | 2,692 | 100,957 | 975,879 | 978.6 K to 975.9 K (-0.28 %) |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.61 | 1,607 | 60,440 | 978,571 | 980.2 K to 978.6 K (-0.16 %) |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 37.50 | 2,692 | 100,957 | 975,879 | 978.6 K to 975.9 K (-0.28 %) |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 37.61 | 1,607 | 60,440 | 978,571 | 980.2 K to 978.6 K (-0.16 %) |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | M | 0.83 | 100,000 | 83,000 | 0 | |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Option Exercise | M | 0.83 | 25,000 | 20,750 | 0 | |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | M | 0.83 | 100,000 | 83,000 | 312,549 | 212.5 K to 312.5 K (+47.05 %) |
| Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Buy | M | 0.83 | 25,000 | 20,750 | 212,549 | 187.5 K to 212.5 K (+13.33 %) |
| Aug 24 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 38.08 | 4,173 | 158,897 | 187,549 | 191.7 K to 187.5 K (-2.18 %) |
| Aug 24 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 38.60 | 4,100 | 158,280 | 191,722 | 195.8 K to 191.7 K (-2.09 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 33.00 | 24,750 | 816,750 | 980,178 | 1 M to 980.2 K (-2.46 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 34.11 | 50 | 1,706 | 1,004,928 | 1 M to 1 M (0.00 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 34.14 | 150 | 5,121 | 1,004,978 | 1 M to 1 M (-0.01 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 33.80 | 50 | 1,690 | 1,005,128 | 1 M to 1 M (0.00 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 33.00 | 24,750 | 816,750 | 195,822 | 220.6 K to 195.8 K (-11.22 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 34.11 | 50 | 1,706 | 220,572 | 220.6 K to 220.6 K (-0.02 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 34.14 | 150 | 5,121 | 220,622 | 220.8 K to 220.6 K (-0.07 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 33.80 | 50 | 1,690 | 220,772 | 220.8 K to 220.8 K (-0.02 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 33.00 | 24,750 | 816,750 | 980,178 | 1 M to 980.2 K (-2.46 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 34.11 | 50 | 1,706 | 1,004,928 | 1 M to 1 M (0.00 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 34.14 | 150 | 5,121 | 1,004,978 | 1 M to 1 M (-0.01 %) |
| May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Thomas | President | Sell | S | 33.80 | 50 | 1,690 | 1,005,128 | 1 M to 1 M (0.00 %) |
| Jan 27 2016 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Option Exercise | M | 5.15 | 15,000 | 77,250 | 0 |